These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17011603)

  • 1. Regional differences in transdermal penetration of fentanyl through equine skin.
    Mills PC; Cross SE
    Res Vet Sci; 2007 Apr; 82(2):252-6. PubMed ID: 17011603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in the in vitro penetration of hydrocortisone through equine skin.
    Mills PC; Cross SE
    J Vet Pharmacol Ther; 2006 Feb; 29(1):25-30. PubMed ID: 16420298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of fentanyl delivered transdermally in healthy adult horses--variability among horses and its clinical implications.
    Orsini JA; Moate PJ; Kuersten K; Soma LR; Boston RC
    J Vet Pharmacol Ther; 2006 Dec; 29(6):539-46. PubMed ID: 17083458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
    Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
    Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent.
    Kress HG; Boss H; Delvin T; Lahu G; Lophaven S; Marx M; Skorjanec S; Wagner T
    Eur J Pharm Biopharm; 2010 Jun; 75(2):225-31. PubMed ID: 20152899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of in vitro transdermal absorption of fentanyl from patches placed on skin samples obtained from various anatomic regions of dogs.
    Mills PC; Magnusson BM; Cross SE
    Am J Vet Res; 2004 Dec; 65(12):1697-700. PubMed ID: 15631036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses.
    Maxwell LK; Thomasy SM; Slovis N; Kollias-Baker C
    Equine Vet J; 2003 Jul; 35(5):484-90. PubMed ID: 12875327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl transdermal absorption linked to pharmacokinetic characteristics in patients undergoing palliative care.
    Van Nimmen NF; Poels KL; Menten JJ; Godderis L; Veulemans HA
    J Clin Pharmacol; 2010 Jun; 50(6):667-78. PubMed ID: 20097932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal fentanyl combined with nonsteroidal anti-inflammatory drugs for analgesia in horses.
    Thomasy SM; Slovis N; Maxwell LK; Kollias-Baker C
    J Vet Intern Med; 2004; 18(4):550-4. PubMed ID: 15320597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal penetration of fentanyl: inter- and intraindividual variations.
    Larsen RH; Nielsen F; Sørensen JA; Nielsen JB
    Pharmacol Toxicol; 2003 Nov; 93(5):244-8. PubMed ID: 14629737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and the effect of application site on a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
    Freise KJ; Newbound GC; Tudan C; Clark TP
    J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():27-33. PubMed ID: 22731773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic reservoir and Durogesic D-Trans matrix transdermal fentanyl patches.
    Van Nimmen NF; Veulemans HA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):264-72. PubMed ID: 17030157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal therapeutic fentanyl-system (TTS-F).
    Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
    In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
    Marier JF; Lor M; Potvin D; Dimarco M; Morelli G; Saedder EA
    J Clin Pharmacol; 2006 Jun; 46(6):642-53. PubMed ID: 16707411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch.
    Oliveira G; Hadgraft J; Lane ME
    Toxicol In Vitro; 2012 Jun; 26(4):645-8. PubMed ID: 22405881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl transdermal analgesia during pregnancy and lactation.
    Cohen RS
    J Hum Lact; 2009 Aug; 25(3):359-61. PubMed ID: 19286842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.